"What we thought was our ally in cancer treatment has actually been a hidden enemy all along," the study's first author said.Continue reading
The stroke care program of Semmelweis University’s Department of Neurosurgery and Neurointerventional Medicine has been awarded the highest diamond level recognition by the European Stroke Organisation (ESO), the institution announced to MTI on Thursday.
They recalled that the ESO’s assessment examines how quickly, how organized, and how professionally patient care is provided.
The clinic provides care continuously, 24 hours a day, according to the highest quality standards, with treatment beginning without delay within one hour of the onset of symptoms,
they wrote.
Over the past year, the clinic has treated more than a thousand cases, including 760 patients in serious condition who required mechanical blood clot removal in addition to thrombolysis, they said.
EvolVeritas, founded by research and discovery scientists from the ELTE Faculty of Science and the HUN-REN Research Center for Natural Sciences, has created a unique drug through the directed evolution of a human protein. The patent-protected EVO24L prevents organ damage following oxygen deprivation. EvolVeritas’s new active ingredient, EVO24L, prevents inflammation as well as destruction by providing a perfect and durable cover for the MASP-2 active site.
Via MTI, Featured photo via Pixabay